Pertussis (Whooping Cough)

Area of Science:

• Immunology
• Infectious Diseases
• Vaccinology

Background:

• Pertussis (whooping cough), caused by Bordetella pertussis, is a highly contagious respiratory infection posing significant risks, especially to young infants.
• While historically prevalent, widespread vaccination has dramatically reduced pertussis incidence.
• Concerns regarding adverse reactions to whole-cell vaccines led to the development and adoption of less reactogenic acellular pertussis vaccines.

Purpose of the Study:

• To summarize the epidemiology and current vaccination strategies for pertussis.
• To highlight the importance of acellular pertussis vaccines in public health.
• To address the growing concern of waning vaccine immunity and the need for new vaccine development.

Main Methods:

• Review of epidemiological data on pertussis incidence and severity.
• Analysis of vaccine efficacy and safety profiles of whole-cell versus acellular pertussis vaccines.
• Examination of current vaccination schedules and recommendations, including infant, childhood, adolescent, and adult/pregnancy boosters.
• Discussion of emerging challenges, such as waning immunity and the evaluation of novel vaccine candidates.

Main Results:

• Acellular pertussis vaccines have significantly decreased disease burden compared to whole-cell vaccines.
• Routine immunization schedules, including boosters during pregnancy, are critical for protecting infants and controlling outbreaks.
• Waning immunity over time is a recognized issue, necessitating ongoing research into improved and longer-lasting pertussis vaccines.

Conclusions:

• Acellular pertussis vaccines are a cornerstone of current pertussis prevention strategies.
• Maternal immunization and timely boosters are essential for safeguarding vulnerable populations, particularly newborns.
• The development of new pertussis vaccines is crucial to overcome challenges related to waning immunity and ensure sustained protection.